PO-164 Identification of the heterogeneous nuclear ribonucleoprotein K/J (hnRNP K/J) as a repressor of the inhibitor kappa B alpha (IκBα) gene in aggressive breast cancer cells
IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a...
Saved in:
Published in | ESMO open Vol. 3; no. Suppl 2; p. A291 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.07.2018
|
Online Access | Get full text |
Cover
Loading…
Abstract | IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a significant role by inducing many target genes involved in tumour progression and drug resistance. Mechanisms controlling constitutive NF-kB activation are not all clearly understood. Among them, repression of the gene encoding the NF-κB inhibitor, IκBα is not well known. This protein controls NF-κB activation by sequestering it in the cytoplasmic compartment. The present study reports the identification of the hnRNP K/J protein, which is initially known for its role in mRNA splicing and translation, as a repressor of the IκBα gene expression.Material and methodsIdentification of hnRNP K/J protein on the IκBα promoter was carried out by DNA pull-down coupled with a mass spectrometry analysis, and chromatin immunoprecipitation (ChIP) using a specific polyclonal antibodies. The hnRNP K/J protein was overexpressed in breast cancer cell lines by transient transfection, and consequence on the IκBα expression and the proximal IκBα promoter activity was evaluated by RT-qPCR and gene reporter assay, respectively. The hnRNP K/J protein localization was visualised in cells by Western blotting using nuclear and cytoplasmic extracts.Results and discussionsThe IκBα gene is expressed higher in nonaggressive compared to aggressive breast cancer cells. We used previous data showing the importance of the proximal promoter at position −495 from the transcription site for DNA pull-down with nuclear protein extract from MCF-7 cells. Mass spectrometry analysis led to identify hnRNP K/J protein, whose the binding to this region of the proximal IκBα promoter was confirmed by ChIP. The IκBα expression at mRNA level and proximal IκBα promoter activity was strongly decreased in hnRNP K/J-overexpressing breast cancer cells, in contrast to the respective parental cells, suggesting the role of hnRNP K/J protein as a gene repressor.ConclusionThe identification of hnRNP K/J as a repressor of IκBα gene expression depicts a new molecular mechanism, which may contribute to the high constitutive NF-kB activation in aggressive breast cancer cells and suggests to take it into account in the development of new therapies targeting NF-kB pathway in advanced breast cancers. |
---|---|
AbstractList | Advanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a significant role by inducing many target genes involved in tumour progression and drug resistance. Mechanisms controlling constitutive NF-kB activation are not all clearly understood. Among them, repression of the gene encoding the NF-κB inhibitor, IκBα is not well known. This protein controls NF-κB activation by sequestering it in the cytoplasmic compartment. The present study reports the identification of the hnRNP K/J protein, which is initially known for its role in mRNA splicing and translation, as a repressor of the IκBα gene expression.
Identification of hnRNP K/J protein on the IκBα promoter was carried out by DNA pull-down coupled with a mass spectrometry analysis, and chromatin immunoprecipitation (ChIP) using a specific polyclonal antibodies. The hnRNP K/J protein was overexpressed in breast cancer cell lines by transient transfection, and consequence on the IκBα expression and the proximal IκBα promoter activity was evaluated by RT-qPCR and gene reporter assay, respectively. The hnRNP K/J protein localization was visualised in cells by Western blotting using nuclear and cytoplasmic extracts.
The IκBα gene is expressed higher in nonaggressive compared to aggressive breast cancer cells. We used previous data showing the importance of the proximal promoter at position −495 from the transcription site for DNA pull-down with nuclear protein extract from MCF-7 cells. Mass spectrometry analysis led to identify hnRNP K/J protein, whose the binding to this region of the proximal IκBα promoter was confirmed by ChIP. The IκBα expression at mRNA level and proximal IκBα promoter activity was strongly decreased in hnRNP K/J-overexpressing breast cancer cells, in contrast to the respective parental cells, suggesting the role of hnRNP K/J protein as a gene repressor.
The identification of hnRNP K/J as a repressor of IκBα gene expression depicts a new molecular mechanism, which may contribute to the high constitutive NF-kB activation in aggressive breast cancer cells and suggests to take it into account in the development of new therapies targeting NF-kB pathway in advanced breast cancers. IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a significant role by inducing many target genes involved in tumour progression and drug resistance. Mechanisms controlling constitutive NF-kB activation are not all clearly understood. Among them, repression of the gene encoding the NF-κB inhibitor, IκBα is not well known. This protein controls NF-κB activation by sequestering it in the cytoplasmic compartment. The present study reports the identification of the hnRNP K/J protein, which is initially known for its role in mRNA splicing and translation, as a repressor of the IκBα gene expression.Material and methodsIdentification of hnRNP K/J protein on the IκBα promoter was carried out by DNA pull-down coupled with a mass spectrometry analysis, and chromatin immunoprecipitation (ChIP) using a specific polyclonal antibodies. The hnRNP K/J protein was overexpressed in breast cancer cell lines by transient transfection, and consequence on the IκBα expression and the proximal IκBα promoter activity was evaluated by RT-qPCR and gene reporter assay, respectively. The hnRNP K/J protein localization was visualised in cells by Western blotting using nuclear and cytoplasmic extracts.Results and discussionsThe IκBα gene is expressed higher in nonaggressive compared to aggressive breast cancer cells. We used previous data showing the importance of the proximal promoter at position −495 from the transcription site for DNA pull-down with nuclear protein extract from MCF-7 cells. Mass spectrometry analysis led to identify hnRNP K/J protein, whose the binding to this region of the proximal IκBα promoter was confirmed by ChIP. The IκBα expression at mRNA level and proximal IκBα promoter activity was strongly decreased in hnRNP K/J-overexpressing breast cancer cells, in contrast to the respective parental cells, suggesting the role of hnRNP K/J protein as a gene repressor.ConclusionThe identification of hnRNP K/J as a repressor of IκBα gene expression depicts a new molecular mechanism, which may contribute to the high constitutive NF-kB activation in aggressive breast cancer cells and suggests to take it into account in the development of new therapies targeting NF-kB pathway in advanced breast cancers. |
Author | Besancenot, V Touche, N Grandemange, S Drouot, G Taverniers, A Becuwe, P |
Author_xml | – sequence: 1 givenname: G surname: Drouot fullname: Drouot, G organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France – sequence: 2 givenname: V surname: Besancenot fullname: Besancenot, V organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France – sequence: 3 givenname: A surname: Taverniers fullname: Taverniers, A organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France – sequence: 4 givenname: S surname: Grandemange fullname: Grandemange, S organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France – sequence: 5 givenname: P surname: Becuwe fullname: Becuwe, P organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France – sequence: 6 givenname: N surname: Touche fullname: Touche, N organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France |
BookMark | eNqNkUFu2zAQRYkiAZo6ucMsnYVikpZoaRkbaeo0qI0gXRMUNbToyqRAKgayy6YHKtBVDpFD9CSV6gbIMqv5GPD_Gc77RI6cd0gIMHrB2FRMMO68b9ElnLI8ubpc3PHsQuTiAznhNCuSGeXF0Rv9kZzFuKWUslnaN8UJ-b1eJUykf55-Lit0nTVWq856B95AVyPU2GHwG3ToHyK4B92gChBs6f9p3wbfoXXwdXID49rdfVsP8hxUBAUB24Ax-vCaZl1tS9v1jR-qbRXMQTVtrWC8fHmev_w6h2FQ_wrUZjM47R6hDKhiB1o5jQE0Nk08JcdGNRHP_tcR-f756n7xJbldXS8Xl7dJySkXSVXxTOesKIwxeWp4ilSZDHU5o5qnWcWE1nlVINeYl5QKo_qrVAxTnitBCzMdkfyQq4OPMaCRbbA7FR4lo3IAIF8ByAGAPACQPYDeOj9Ysd9vbzHIqC32X6hsQN3Jytv3hEwPIeVu-_7RfwHgS6ne |
ContentType | Journal Article |
Copyright | 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 © 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. |
Copyright_xml | – notice: 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: 2018 © 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. |
DBID | 9YT ACMMV 6I. AAFTH AAYXX CITATION |
DOI | 10.1136/esmoopen-2018-EACR25.686 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2059-7029 |
EndPage | A291 |
ExternalDocumentID | 10_1136_esmoopen_2018_EACR25_686 S2059702920317312 |
GroupedDBID | .1- .FO 0R~ 0SF 53G 5VS 9YT AAEDW AALRI AAXUO ACGFS ACMMV ADBBV ADRAZ ADVLN AFRHN AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BCNDV EBS FDB GROUPED_DOAJ HYE KQ8 M48 M~E O9- OK1 RHI ROL RPM Z5R 6I. AAFTH AFCTW AAYXX AFJKZ CITATION |
ID | FETCH-LOGICAL-b2026-dd25c8199fff84f24e0af5ecb70c245d16cc8d9e2ce8b006fa742d1e428a609f3 |
IEDL.DBID | 9YT |
ISSN | 2059-7029 |
IngestDate | Thu Sep 26 17:50:06 EDT 2024 Thu Jul 20 20:16:52 EDT 2023 Wed Aug 21 03:27:02 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl 2 |
Language | English |
License | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0 This is an open access article under the CC BY-NC license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b2026-dd25c8199fff84f24e0af5ecb70c245d16cc8d9e2ce8b006fa742d1e428a609f3 |
OpenAccessLink | http://dx.doi.org/10.1136/esmoopen-2018-EACR25.686 |
ParticipantIDs | crossref_primary_10_1136_esmoopen_2018_EACR25_686 elsevier_sciencedirect_doi_10_1136_esmoopen_2018_EACR25_686 bmj_primary_10_1136_esmoopen_2018_EACR25_686 |
PublicationCentury | 2000 |
PublicationDate | 20180700 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 20180700 |
PublicationDecade | 2010 |
PublicationTitle | ESMO open |
PublicationYear | 2018 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
SSID | ssj0001742056 |
Score | 2.0834324 |
Snippet | IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour... Advanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression... |
SourceID | crossref elsevier bmj |
SourceType | Aggregation Database Publisher |
StartPage | A291 |
SummonAdditionalLinks | – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dTxQxFG0QEuOLUdSIH-Q--ACJhZlupzsTYwgQCGJAQtyEt0m_LrsgM-vsmujPkkd-BL_J285M4gPR6NM0mWkn6bltz2lv72XsjZeOVqXCcK0VcplKw41RGcfEu2HunMMYu_PoWB2M5OFZdrbA-uuKXQfO7pR2IZ_UqPmy8f3rjy0a8O-7jCSbfnZVh3eEeJrzve3dU5FtqFzdY0tCkl4PDn0d6Y87L6QGk5jWlR4FHyai6F18_tAYrT3m6uLu1eu3FWn_EXvYUUnYbrF_zBZ8tczuH3WH5U_Y9cknTjIF2ru42G3OQY1ApA_GwQ-mJvPxpP2hCmGNdQPNxNSxXMcADpMKPm4ewtq4Oj0-CcV10DPQ0LT-s3XTtzapxhNDk0MDl3o61bAD8RIvrH24vdm5_bkO4Uf0FejzKPBpjgUT_OHnYIPdNRBOEGZP2Wh_7_PuAe9SNHAjSL1x50RmiVQUiJhLFNInGjNvzTCxQmYuVdbmrvDC-jwMcNTU-S71JHq0SgocPGOLVV355wyQeL7yKAqboEzQa114S2pODQYYVN0Ke0sAlNM2CEcZxctAlT1eZcCrbPEqCa8VlvZI_UOddz2kZUdAWmJRkrn9tfaL__jjS_Yg2ln0_33FFufNN_-aWM7crEaj_QXZDfvJ priority: 102 providerName: Scholars Portal |
Title | PO-164 Identification of the heterogeneous nuclear ribonucleoprotein K/J (hnRNP K/J) as a repressor of the inhibitor kappa B alpha (IκBα) gene in aggressive breast cancer cells |
URI | http://dx.doi.org/10.1136/esmoopen-2018-EACR25.686 https://dx.doi.org/10.1136/esmoopen-2018-EACR25.686 |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELZKKyEuFb-iBVZz4NBKmObHcRNx2q5alaKUqmpROUX-m-6Cmqyyy50LD4TEiYfoQ_AkjJ1EcKhAvUQ-xE6Ub5z5Ps94zNhLJyx5pUJzpSRyEQvNtZYZx8jZ3dxai6F2Z3ksD8_F0UV2scKSmyP4cSp33OKq8SdJEZ5xzvfHk9Mkey1zeYet-dLlfjIWH8_-rKuQ1iOnPiTt_GMA8ib66tPN_ugvH3Nwn6335BDGHZoP2IqrH7K7ZR_-fsR-nLznJDx-ff3W7a_FfsENGgQicjD1uS0NmYQjPQ-1L1WsWmhnugntJhRlmNXwbucItqb16fGJb26DWoCCtsuJbdphtFk9nWma8C18VvO5gj0IG3Nh6-31z73r79vgH0R3gboMop3-m6B9jvsSjLelFnxUYPGYnR_sn00OeX_sAtcJKTJubZIZIgoFIuYCE-EihZkzejcyichsLI3JbeES43I_aVHRJ7exIyGjZFRg-oSt1k3tnjJA4u7SYVKYCEWETqnCGVJoMk3RK7UN9oogqOZdYY0qCJJUVgNilUes6hCrCLENFg9Y3aLPmwHUqicVHVmoyND-23vzdi_4jN0LRhbSeZ-z1WX7xb0g0rLUo2ClI7Y2npTlh1GQ_nQtRf4b9aDvUA |
link.rule.ids | 315,783,787,867,24330,27561,27562,27868,27936,27937 |
linkProvider | BMJ Publishing Group Ltd |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PO-164+Identification+of+the+heterogeneous+nuclear+ribonucleoprotein+K%2FJ+%28hnRNP+K%2FJ%29+as+a+repressor+of+the+inhibitor+kappa+B+alpha+%28I%CE%BAB%CE%B1%29+gene+in+aggressive+breast+cancer+cells&rft.jtitle=ESMO+open&rft.au=Drouot%2C+G.&rft.au=Besancenot%2C+V.&rft.au=Taverniers%2C+A.&rft.au=Grandemange%2C+S.&rft.date=2018-07-01&rft.issn=2059-7029&rft.eissn=2059-7029&rft.volume=3&rft.spage=A291&rft_id=info:doi/10.1136%2Fesmoopen-2018-EACR25.686&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_esmoopen_2018_EACR25_686 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-7029&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-7029&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-7029&client=summon |